z-logo
open-access-imgOpen Access
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
Author(s) -
Christoph Licht,
Stefan Heinen,
Mihály Józsi,
Ina Löschmann,
Rebecca E. Saunders,
Stephen J. Perkins,
R Waldherr,
Christine Skerka,
Michael Kirschfink,
Bernd Höppe,
Peter F. Zipfel
Publication year - 2006
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/sj.ki.5000269
Subject(s) - factor h , membranoproliferative glomerulonephritis , complement factor i , mutant , complement system , complement factor b , alternative complement pathway , wild type , biology , glomerulonephritis , mutant protein , antibody , chemistry , immunology , microbiology and biotechnology , medicine , endocrinology , kidney , biochemistry , gene
We report a novel pathomechanism for membranoproliferative glomerulonephritis type II (MPGN II) caused by a mutant Factor H protein expressed in the plasma. Genetic analyses of two patients revealed deletion of a single Lys residue (K224) located within the complement regulatory region in domain 4 of Factor H. This deletion resulted in defective complement control: mutant protein purified from the plasma of patients showed severely reduced cofactor and decay-accelerating activity, as well as reduced binding to the central complement component C3b. However, cell-binding activity of the mutant protein was normal and comparable to wild-type Factor H. The patients are daughters of consanguineous parents. As both patients but also their healthy mother were positive for C3 nephritic factor, the mutant Factor H protein is considered relevant for unrestricted activation of the disease-causing activation of the alternative complement pathway. Replacement of functional Factor H by fresh frozen plasma (10-15 ml/kg/14 days) was well tolerated, prevented so far disease progression in both patients, and is in the long run expected to preserve kidney function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom